Healius HLS.AX · AUD

Its shares trade on ASX under the ticker HLS.AX. It has been listed since 3 July 1998. In the fiscal year to 30 June 2026, it reported revenue of A$1.37bn and a net loss of A$415.6m. At that date it held total assets of A$1.42bn and shareholders' equity of A$171.5m.

Healius Ltd. engages in the provision of healthcare technology solutions. The company is headquartered in Sydney, New South Wales. The firm also operates as a provider of diagnostic imaging services; a provider of pathology services, and a provider of health technology. The company provides a range of services and facilities to healthcare practitioners, and its medical center operations include the provision of day surgery and in vitro fertilization services by healthcare practitioners. Its segments include Medical Centres, Pathology, Imaging, Health Technology and Other. The Medical Centres division provides services and facilities to general practitioners, specialists and other healthcare providers, and includes Transport Health. The Pathology division provides pathology services. The Imaging division provides imaging and scanning services from standalone imaging sites and from within the consolidated entity's medical centers. The Health Technology division develops, sells and supports health-related software products.

Figures and description from our data supplier, not checked against the company's own report.

• Ms. Kathryn MckenzieInterim Non-Executive Independent Chairman of the BoardA$269,984
• Mr. Paul AndersonChief Executive Officer, Managing Director, Director, since 2023A$944,623
• Mr. Stephen HumphriesChief Financial Officer, Company SecretaryA$262,964
• Mr. Prasad AravGroup Executive - Digital and Technology and Strategy
• Ms. Paula BaylissGroup Executive - People & Culture
• Dr. Phil LucasGroup Executive - Lumus Imaging
• Dr. Michael StanfordNon-Executive DirectorA$138,743
• Mr. Neil VinsonNon-Executive Director
• Ms. Sally EvansNon-Executive Independent DirectorA$185,000
• Prof. John MattickNon-Executive Independent DirectorA$170,000
• Ms. Katherine OstinNon-Executive Independent Director
• Mr. Charles TaylorNon-Executive Independent DirectorA$174,821

Overall

64

Environment

99

Social

53

Governance

39

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.